Tri-City Cardiology
Mesa, Arizona, United States
Cardiologist in Mesa, Arizona
6750 E Baywood Ave #301, Mesa, AZ 85206
About Tri-City Cardiology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tri-City Cardiology
During the past decade, Tri-City Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)
2004-09-13
2008-01-31
Completed
10
Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients
2009-12-01
2016-04-01
Completed
37
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
2011-09-27
2016-08-10
Completed
295
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
2012-02-21
2019-08-22
Completed
605
Observational Study of Pediatric Acute Kidney Injury, Risk Factors and Outcomes
2014-01-01
2014-12-01
Completed
5,237
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
2014-09-16
2018-03-13
Completed
175
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
2017-03-27
2022-05-24
Completed
290
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tri-City Cardiology"
#1 collaborator was "Milton S. Hershey Medical Center" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Tri-City Cardiology
According to Clinical.Site data, the most researched conditions in "Tri-City Cardiology" are
"Heart Failure" (2 trials), "Atherosclerosis" (1 trials), "CIED Related Infection" (1 trials), "Coronary Artery Disease" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Tri-City Cardiology" in a lesser frequency.
Clinical Trials Intervention Types at Tri-City Cardiology
Most popular intervention types in "Tri-City Cardiology" are "Device" (4 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "ACUITY Spiral Left Ventricular Lead" (1 trials), "AGI-1067" (1 trials), "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials) and "COGNIS CRT-D" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tri-City Cardiology
The vast majority of trials in "Tri-City Cardiology" are
5 trials for "All" genders.
Clinical Trials Status at Tri-City Cardiology
Currently, there are NaN active trials in "Tri-City Cardiology".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Tri-City Cardiology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tri-City Cardiology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".